# US 2008/0306584 A1 · Implantable medical devices for local and regional treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306584 A1
- Document ID: US20080306584A1
- Status: Published application
- Kind: A1
- Application number: 11/810,518
- Filed: 2007-06-05
- Published: 2008-12-11
- Earliest claimed: 2007-06-05
- Inventors: Pamela Kramer-Brown
- Web page: https://patentgrep.com/patent/US20080306584A1

## CPC

- A61L 31/10: Macromolecular materials
- A61L 31/088: {Other specific inorganic materials not covered by A61L31/084 or A61L31/086}
- A61L 31/127: {containing fillers of phosphorus-containing inorganic materials}
- A61L 31/14: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61L 31/148: {Materials at least partially resorbable by the body}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61L 2300/604: Biodegradation
- A61L 2300/608: having two or more layers
- A61L 2300/624: Nanocapsules
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)

## Abstract

Implantable medical devices adapted to erodibly release delivery media for local and regional treatment are disclosed.

## Claims

### Claim 1

A stent comprising a scaffolding formed from a corrodible metal having one or more recesses in a surface of the scaffolding, the recesses being at least partially filled with a plurality of releasable delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from an implanted stent.

### Claim 2 (depends on 1)

The method of claim 1, wherein the delivery media allows for sustained-release of active agent into a body of a patient upon release of the delivery media from the implanted stent.

### Claim 3 (depends on 1)

The method of claim 1 wherein the metal is porous.

### Claim 4 (depends on 1)

The method of claim 1 wherein the metal has a porosity of at least 50%.

### Claim 5 (depends on 1)

The method of claim 1 wherein the metal dissolves upon exposure to bodily fluids.

### Claim 6 (depends on 1)

The method of claim 1 wherein the metal comprises a combination of two or more metals selected to create a galvanic couple such that the metal undergoes galvanic dissolution upon contact with bodily fluids.

### Claim 7 (depends on 1)

The method of claim 1 wherein the recesses comprise a plurality of depots in the surface of the substrate.

### Claim 8 (depends on 1)

The method of claim 1 wherein the recesses are on a luminal surface of the stent.

### Claim 9 (depends on 1)

The method of claim 1 wherein the recesses are on an abluminal surface of the stent.

### Claim 10 (depends on 1)

The method of claim 1 wherein the delivery media are mixed or dispersed in an erodible polymer, wherein at least some of the delivery media are released from the implanted stent upon erosion of the erodible polymer.

### Claim 11 (depends on 1)

The method of claim 1 further comprising an erodible coating above the opening of the depots, the coating adapted to delay the release of the delivery media from the implanted stent.

### Claim 12 (depends on 1)

The method of claim 1 wherein the delivery media comprise nanoparticles, wherein an active agent is encapsulated within, coated on, or dispersed within the nanoparticles.

### Claim 13

A stent comprising a scaffolding including at least two erodible polymer layers, wherein at least one of the polymer layers comprises a plurality of delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon erosion of the at least one polymer layer.

### Claim 14 (depends on 13)

The stent of claim 13 wherein the delivery media allows for sustained-release of the active agent into a body of a patient upon release of the delivery media from the implanted stent.

### Claim 15 (depends on 13)

The stent of claim 13 wherein the plurality of delivery media comprise a plurality of particles comprising the active agent.

### Claim 16 (depends on 13)

The stent of claim 13 wherein at least two of the polymer layers comprise the same delivery media.

### Claim 17 (depends on 13)

The stent of claim 13 wherein at least two of the polymer layers comprise different delivery media.

### Claim 18 (depends on 13)

The stent of claim 13 wherein at least one of the polymer layers comprises a polymer having a greater stiffness than at least one of the other polymer layers.

### Claim 19 (depends on 13)

The stent of claim 13 wherein at least one of the polymer layers comprises a filler material that modifies an erosion rate of the scaffolding.

### Claim 20 (depends on 19)

The stent of claim 19 wherein the filler has basic degradation products that decrease the erosion rate of the stent scaffolding.

### Claim 21 (depends on 20)

The stent of claim 20 wherein the filler is hydroxyapatite.

### Claim 22

A stent comprising a scaffolding including at least two erodible polymer layers, wherein at least one of the polymer layers comprises a plurality of delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon erosion of the at least one polymer layer, wherein at least one of the polymer layers comprises a filler material that modifies an erosion rate of the scaffolding, wherein the filler has basic degradation products that decrease the erosion rate of the stent scaffolding.

### Claim 23

A stent comprising a scaffolding including struts having an abluminal layer, a luminal layer, and a middle layer between the abluminal layer and the luminal layer, each of the layers being formed from erodible polymers, wherein a plurality of delivery media are dispersed within the abluminal layer or luminal layer, wherein an active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding of an implanted stent during erosion of the abluminal layer or luminal layer releases the delivery media from the scaffolding.

### Claim 24 (depends on 23)

The stent of claim 23 wherein the middle layer comprises a polymer having a greater stiffness than the abluminal and luminal polymer layers, thereby providing structural support to the scaffolding.

### Claim 25 (depends on 23)

The stent of claim 23 wherein at least one of the polymer layers comprises a filler material that modifies an erosion rate of the scaffolding.

### Claim 26 (depends on 25)

The stent of claim 25 wherein the filler has basic degradation products that decrease the erosion rate of the stent scaffolding.

### Claim 27 (depends on 26)

The stent of claim 26 wherein the filler is hydroxyapatite.

### Claim 28

A stent comprising erodible polymer struts having an abluminal layer, a luminal layer, and a middle layer, wherein a plurality of delivery media comprising an active agent are dispersed within the abluminal layer or luminal layer, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding, wherein erosion of the abluminal layer or luminal layer releases the delivery media from the scaffolding, wherein at least one of the layers comprises a filler material that modifies an erosion rate of the scaffolding, wherein the filler has basic degradation products that decrease the erosion rate of the stent scaffolding, and wherein the filler is hydroxyapatite.

### Claim 29

A method of fabricating a stent comprising:
co-extruding a tube including at least two erodible polymer layers, wherein at least one of the two erodible polymer layers comprises a plurality of delivery media comprising an active agent; and
cutting a stent pattern in the tube to form a stent scaffolding including at least two erodible polymer layers, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the polymer layer of an implanted stent due to erosion of the at least two polymer layers.

### Claim 30 (depends on 29)

The method of claim 29 wherein the plurality of delivery media comprise a plurality of particles comprising the active agent.

### Claim 31

A stent comprising a scaffolding having an erodible polymer layer and an erodible metal layer, wherein at least one of the layers comprises a plurality of delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding of an implanted stent due to erosion of one of the scaffolding layers.

### Claim 32 (depends on 31)

The stent of claim 31 wherein one of the layers is an abluminal layer and the other layer is a luminal layer.

### Claim 33 (depends on 31)

The stent of claim 31 wherein the delivery media allows for sustained-release of an active agent into a body of a patient upon release of the delivery media from the scaffolding of an implanted stent.

### Claim 34 (depends on 31)

The stent of claim 31 wherein the polymer layer comprises the delivery media.

### Claim 35 (depends on 31)

The stent of claim 31 wherein the metal layer comprises the delivery media.

### Claim 36 (depends on 31)

The stent of claim 31 wherein the erosion rate of the metal and polymer layers is different, allowing for staged release of an active agent into a body of a patient upon release of the delivery media.

### Claim 37 (depends on 31)

The stent of claim 31 wherein the delivery media are disposed within a recess in a surface of at least one of the layers.

### Claim 38 (depends on 31)

The stent of claim 31 wherein the delivery media are dispersed within the polymer layer.

### Claim 39 (depends on 31)

The stent of claim 31 wherein the delivery media are dispersed within an erodible coating disposed above at least one of the layers.

### Claim 40 (depends on 31)

The stent of claim 31 wherein the metal layer is formed from a metal selected from the group consisting of magnesium, manganese, potassium, calcium, sodium, zinc, chromium, iron, cadmium, aluminum, cobalt, vanadium, copper, molybdenum, antimony, and alloys thereof.

### Claim 41

A stent comprising a scaffolding having an erodible polymer layer and an erodible metal layer, wherein at least one of the layers comprises a plurality of delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding of an implanted stent due to erosion of one of the layers, and wherein the metal layer is formed from a metal selected from the group consisting of magnesium, manganese, potassium, calcium, sodium, zinc, chromium, iron, cadmium, aluminum, cobalt, vanadium, copper, molybdenum, antimony, and alloys thereof.

### Claim 42

A stent comprising a scaffolding including an erodible polymer layer between two erodible metal layers, at least one of the layers comprising a plurality of releasable delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from an implanted stent.

### Claim 43 (depends on 42)

The stent of claim 42 wherein the metallic layers comprise an abluminal layer and a luminal layer.

### Claim 44 (depends on 42)

The stent of claim 42 wherein the metal layers delay release of the delivery media from the polymer layer allowing for staged release of the active agents into a body of a patient upon release of the delivery media from the metal and polymer layers.

### Claim 45 (depends on 42)

The stent of claim 42 wherein the metal layers provide structural support during release of the delivery media from the polymer layer.

### Claim 46 (depends on 42)

The stent of claim 42 wherein erosion of the metal layers is delayed by the polymer layer.

### Claim 47 (depends on 42)

The stent of claim 42 wherein the metal layers are self-dissolving.

### Claim 48 (depends on 30)

The stent of claim 30 wherein the metal layers are a galvanic couple that undergo galvanic erosion upon contact.

### Claim 49 (depends on 42)

The stent of claim 42 wherein the delivery media allow for sustained-release of active agent into a body of a patient upon release of the delivery media from the implanted stent.

### Claim 50 (depends on 42)

The stent of claim 42 wherein the metal layers are formed from a metal selected from the group consisting of magnesium, manganese, potassium, calcium, sodium, zinc, chromium, iron, cadmium, aluminum, cobalt, vanadium, copper, molybdenum, antimony, and alloys thereof.

### Claim 51

A method of fabricating a stent comprising:
forming a layered tube comprising an erodible polymer layer within or around an erodible metallic tube, wherein the erodible polymer layer comprises a plurality of delivery media comprising an active agent; and
cutting a stent pattern in the layered tube to form a stent scaffolding, the stent scaffolding having an erodible metallic layer and an erodible polymer layer, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding of an implanted stent.

### Claim 52 (depends on 51)

The method of claim 51 wherein the erodible polymer layer is formed by co-extruding the erodible polymer layer within or around the erodible metallic tube.

### Claim 53 (depends on 51)

The method of claim 51 wherein the erodible polymer layer is formed by coating the erodible metallic tube.

### Claim 54 (depends on 51)

The method of claim 51 further comprising forming a cavity in the erodible metallic layer of the scaffolding and disposing a plurality of delivery media within the cavity.

### Claim 55

A method of fabricating a stent comprising:
forming a layered tube comprising an erodible polymer layer within or around an erodible metallic tube, wherein the erodible polymer layer comprises a plurality of delivery media comprising an active agent;
cutting a stent pattern in the layered tube to form a stent scaffolding, the stent scaffolding having an erodible metallic layer and an erodible polymer layer, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the scaffolding of an implanted stent;
forming a cavity in the erodible metallic layer of the scaffolding; and
disposing a plurality of delivery media within the cavity.

### Claim 56

A method of forming a stent, comprising:
forming a gel mixture comprising an erodible polymer, solvent, and a plurality of delivery media, the delivery media comprising an active agent;
processing the gel mixture to form a tube, the erodible polymer and the delivery media dispersed within the tube; and
forming a stent from the tube.

### Claim 57 (depends on 56)

The method of claim 56 wherein the gel mixture is processed at or near room temperature.

### Claim 58 (depends on 56)

The method of claim 56 wherein the erodible polymer comprises poly vinyl alcohol (PVA) or a block copolymer of poly(L-lactide-glycolic acid)(PLGA).

### Claim 59 (depends on 56)

The method of claim 56 wherein the solvent is selected from the group consisting of water, benzyl benzoate, ethyl benzoate, and benzyl alcohol.

### Claim 60 (depends on 56)

The method of claim 56 wherein the gel mixture is formed in a mixing apparatus selected from the group consisting of a batch mixer and an extruder.

### Claim 61 (depends on 56)

The method of claim 56 wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the implanted stent.

### Claim 62 (depends on 56)

The method of claim 56 wherein the processing comprises extruding the gel mixture to form the tube.

### Claim 63 (depends on 56)

The method of claim 56 wherein the solvent is removed from the gel mixture during and after forming the tube.

### Claim 64 (depends on 63)

The method of claim 63 wherein the solvent is removed by cooling the gel mixture with a cooling fluid.

### Claim 65

A method of forming a stent, comprising:
forming a gel mixture comprising an erodible polymer, solvent, and a plurality of delivery media, the delivery media comprising an active agent;
processing the gel mixture to form a tube, the erodible polymer and the delivery media dispersed within the tube;
forming a stent from the tube; and
removing the solvent from the gel mixture during and after forming the tube by cooling the gel mixture with a cooling fluid.

### Claim 66 (depends on 65)

The method of claim 65 wherein the processing comprises coextruding the gel mixture around or within a polymer or metallic tube to form the tube, wherein the tube comprises a layer formed from the gel mixture and a layer comprising the polymer or metallic tube.

### Claim 67

A method of forming a stent, comprising:
forming a gel mixture comprising an erodible polymer, solvent, and a plurality of delivery media, the delivery media comprising an active agent;
processing the gel mixture to form a tube, the erodible polymer and the delivery media dispersed within the tube, wherein the processing comprises coextruding the gel mixture around or within a polymer or metallic tube to form the tube, wherein the tube comprises a layer formed from the gel mixture and a layer comprising the polymer or metallic tube; and
forming a stent from the tube.

### Claim 68 (depends on 67)

The method of claim 67 wherein the stent is formed by cutting a stent pattern in the tube.

### Claim 69

A method of forming a stent, comprising:
forming a gel mixture comprising an erodible polymer, solvent, and a plurality of delivery media comprising an active agent;
fabricating a tube from the gel mixture with a forming apparatus, the tube including a layer comprising the erodible polymer and the delivery media dispersed within the layer; and
forming a stent from the tube.

### Claim 70 (depends on 69)

The method of claim 69 wherein the gel mixture is processed at or near room temperature.

### Claim 71 (depends on 69)

The method of claim 69 wherein the forming apparatus comprises an extruder.

### Claim 72 (depends on 69)

The method of claim 69 wherein the forming apparatus comprises an extruder and a die.

### Claim 73 (depends on 69)

The method of claim 69 wherein the gel mixture is coextruded around or within a polymer or metallic tube to form the tube, wherein the tube comprises the layer formed from the gel mixture and a layer comprising the polymer or metallic tube.

### Claim 74 (depends on 69)

The method of claim 69 wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the stent upon implantation.

### Claim 75

A method of forming a stent, comprising:
forming a gel mixture comprising an erodible polymer, solvent, and a plurality of delivery media comprising an active agent, wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the stent upon implantation;
fabricating a tube from the gel mixture with a forming apparatus, the tube including a layer comprising the erodible polymer and the delivery media dispersed within the layer; and
forming a stent from the tube.

### Claim 76

A stent comprising a structural element having a cavity disposed therein including a plurality of releasable delivery media comprising an active agent, wherein an osmotic pressure gradient between the cavity and the surface of the structural element releases the delivery media from the cavity.

### Claim 77 (depends on 76)

The stent of claim 76 wherein the active agent is adapted to be released from the delivery media upon release of the delivery media from the implanted stent.

### Claim 78 (depends on 76)

The stent of claim 76 wherein the opening is on an abluminal surface or a luminal surface of the structural element.

### Claim 79 (depends on 76)

The stent of claim 76 wherein the structural element comprises a coating layer covering the cavity, an opening being through the coating layer.

### Claim 80 (depends on 79)

The stent of claim 79 wherein the coating is erodible.

### Claim 81

A stent comprising a structural element having a cavity disposed therein including a plurality of releasable delivery media, wherein an osmotic pressure gradient between the cavity and a surface of the structural element releases the delivery media from the cavity, wherein the structural element comprises a coating layer covering the cavity, an opening being through the coating layer, and wherein the coating is erodible.

### Claim 82 (depends on 76)

The stent of claim 76 wherein the osmotic pressure gradient is formed by a difference in concentration of the delivery media or an active agent in the cavity and at the surface of the structural element.

### Claim 83 (depends on 76)

The stent of claim 76 wherein the osmotic pressure gradient is formed by a difference in concentration of an additive in the cavity and at the surface of the structural element.

### Claim 84 (depends on 83)

The stent of claim 83 wherein the additive is a salt.

### Claim 85

A stent comprising a structural element having a cavity disposed therein including a plurality of releasable delivery media, wherein an osmotic pressure gradient between the cavity and a surface of the structural element releases the delivery media from the cavity, wherein the osmotic pressure gradient is formed by a difference in concentatrion of an additive in the cavity and at the surface of the structural element, and wherein the additive is a salt.

### Claim 86 (depends on 76)

The stent of claim 76 wherein the structural element is formed from an erodible metal.

### Claim 87

A stent comprising a structural element having a cavity disposed therein including a plurality of releasable delivery media comprising an active agent, wherein an opening between the cavity and a surface of the structural element, wherein an osmotic pressure gradient between the cavity and the surface of the structural element releases the delivery media through the opening from an implanted stent, and wherein the structural element is formed from an erodible metal.

### Claim 88 (depends on 76)

The stent of claim 76 wherein the structural element is formed from a metal selected from the group consisting of magnesium, manganese, zinc, chromium, iron, aluminum, cobalt, tin, vanadium, copper, and molybdenum.

### Claim 89

A stent comprising a structural element having a cavity disposed therein including a plurality of releasable delivery media comprising an active agent, wherein an osmotic pressure gradient between the cavity and a surface of the structural element releases the delivery media through an opening between the cavity and the surface of the structural element, and wherein the structural element is formed from a metal selected from the group consisting of magnesium, manganese, zinc, chromium, iron, aluminum, cobalt, tin, vanadium, copper, and molybdenum.

### Claim 90

A stent comprising an erodible scaffolding, the scaffolding comprising a plurality of releasable particles, wherein the particles comprise an active agent and are adapted to be released from the stent upon erosion of the scaffolding.

### Claim 91 (depends on 90)

The stent of claim 90 wherein the active agent is adapted to be released from the particles upon release of the particles from the scaffolding.

### Claim 92 (depends on 90)

The stent of claim 90 wherein the particles are nanoparticles.

### Claim 93 (depends on 90)

The stent of claim 90 wherein the particles are incorporated on or within the scaffolding with an erodible binder, the binder holding the particles together on or within the scaffolding.

### Claim 94 (depends on 90)

The stent of claim 90 wherein the particles are disposed within a recess in a surface of the scaffolding.

### Claim 95 (depends on 90)

The stent of claim 90 wherein the particles are dispersed within an erodible binder disposed above the surface of the scaffolding.

### Claim 96 (depends on 90)

The stent of claim 90 wherein the active agent is encapsulated within, coated on, or dispersed within the particles.

### Claim 97 (depends on 90)

The stent of claim 90 wherein at least a portion of the scaffolding is formed from an erodible polymer.

### Claim 98 (depends on 90)

The stent of claim 90 wherein at least a portion of the scaffolding is formed from an erodible metal.

### Claim 99 (depends on 90)

The stent of claim 90 wherein the particles are formed from a precipitate of a neat bioactive agent.

### Claim 100 (depends on 90)

The stent of claim 90 wherein the particles comprise a polymer and a drug.

### Claim 101 (depends on 90)

The stent of claim 90 wherein the particles comprise a drug impregnated core and a bioerodible coating.

### Claim 102 (depends on 90)

The stent of claim 90 wherein the particles comprise a fullerene with a bioactive agent coating.

### Claim 103 (depends on 90)

The stent of claim 90 wherein the particles are selected from the group consisting of polymerosome, micelle, vesicle, liposome, biodegradable glass, biostable glass, carbon nanotube and micronized drug.

### Claim 104 (depends on 90)

The stent of claim 90 wherein the particles are formed from a material selected from the group consisting of bioabsorbable polymer, biostable polymer, biosoluble material, biopolymer, biostable metal, biocrodible metal, block copolymer of a bioabsorbable polymer, block copolymer of a biopolymer, ceramic, salt, lipid, and a combination thereof.

### Claim 105 (depends on 90)

The stent of claim 90 wherein a surface of the particles are adapted to bind to a portion of vasculature.

### Claim 106 (depends on 90)

The stent of claim 90 wherein a surface of the particles comprises a substance incorporated into the surface for selectively binding the surface to a portion of the vasculature, the substance selected from the group consisting of a peptide, an antibody, a small-molecular ligand, and a specific receptor having an affinity to receptors found on endothelial cells.

### Claim 107

A stent comprising an erodible scaffolding, the scaffolding comprising a plurality of releasable particles, wherein the particles comprise an active agent and are adapted to be released from the stent upon erosion of the scaffolding, and wherein the active agent is adapted to be released from the particles upon release of the particles from the scaffolding.

### Claim 108

A stent comprising an erodible scaffolding, the scaffolding comprising a plurality of releasable particles, wherein the particles comprise an active agent and are adapted to be released from the stent upon erosion of the scaffolding, and wherein the particles are incorporated on or within the scaffolding with an erodible binder, the binder holding the particles together on or within the scaffolding.

### Claim 109

A stent comprising an erodible scaffolding, the scaffolding comprising a plurality of releasable particles, wherein the particles comprise an active agent and are adapted to be released from the stent upon erosion of the scaffolding, and wherein the particles are dispersed within an erodible binder disposed above the surface of the scaffolding.

### Claim 110

A stent comprising an erodible scaffolding, the scaffolding comprising a plurality of releasable particles, wherein the particles comprise an active agent and are adapted to be released from the stent upon erosion of the scaffolding, and wherein the active agent is encapsulated within, coated on, or dispersed within the particles.

### Claim 111

A method of treating a patient vasculature, comprising:
deploying a stent at an implant site of a vasculature, the stent comprising a scaffolding formed from erodible material, the scaffolding comprising a plurality of releasable delivery media comprising an active agent; and
allowing the delivery media to release from the scaffolding and be transported to a target region of the vasculature.

### Claim 112 (depends on 111)

The method of claim 111 further comprising allowing the delivery media to bind to the target region of the vasculature.

### Claim 113 (depends on 111)

The method of claim 111 wherein a surface of the delivery media is adapted to bind to the target region of the vasculature.

### Claim 114 (depends on 111)

The method of claim 111 wherein a surface of the delivery media comprises a substance incorporated into the surface for selectively binding the surface to a portion of the vasculature, the substance selected from the group consisting of a peptide, an antibody, a small-molecular ligand, and a specific receptor having an affinity to receptors found on endothelial cells.

### Claim 115 (depends on 111)

The method of claim 111 wherein the erodible material comprises an erodible polymer, erodible metal, or a combination thereof.

### Claim 116 (depends on 111)

The method of claim 111 wherein the active agent is released from the delivery media upon release of the delivery media from the scaffolding.

### Claim 117 (depends on 111)

The method of claim 111 wherein the active agent is released from the delivery media during transport and at the target region of the vasculature.

### Claim 118 (depends on 111)

The method of claim 111 wherein the released delivery media provide sustained-release of the active agent into the vasculature.

### Claim 119 (depends on 111)

The method of claim 111 wherein the delivery media is released from the scaffolding due to erosion of the erodible material.

### Claim 120 (depends on 111)

The method of claim 111 wherein the delivery media is released into the vasculature and transported within the blood.

### Claim 121 (depends on 111)

The method of claim 111 wherein the delivery media is released into and transported through the vascular wall to the target region.

### Claim 122 (depends on 111)

The method of claim 111 wherein the delivery media is released from a luminal surface of the scaffolding.

### Claim 123 (depends on 111)

The method of claim 111 wherein the delivery media is released from an abluminal surface of the scaffolding.

### Claim 124 (depends on 111)

The method of claim 111 wherein the delivery media is released from a surface between an abluminal surface and a luminal surface of the scaffolding.

### Claim 125 (depends on 111)

The method of claim 111 wherein the target region of the vasculature is distal to the implant site of the stent.

### Claim 126 (depends on 111)

The method of claim 111 wherein the target region of the vasculature is proximal to the scaffolding.

### Claim 127 (depends on 111)

The method of claim 111 wherein the delivery media are incorporated on or within the scaffolding with an erodible binder, the binder holding the particles together on or within the scaffolding.

### Claim 128 (depends on 127)

The method of claim 127 wherein the binder comprises a biodegradable polymer or a water soluble polymer.

### Claim 129

A method of treating a patient vasculature, comprising:
deploying a stent at an implant site of a vasculature, the stent comprising a scaffolding formed from erodible material, the scaffolding comprising a plurality of releasable delivery media comprising an active agent, wherein the delivery media are incorporated on or within the scaffolding with an erodible binder, the binder holding the particles together on or within the scaffolding, and wherein the binder comprises a biodegradable polymer or a water soluble polymer; and
allowing the delivery media to release from the scaffolding and be transported to a target region of the vasculature.

### Claim 130 (depends on 129)

The method of claim 129 wherein the delivery media are disposed within a recess in a surface of the scaffolding.

### Claim 131 (depends on 129)

The method of claim 129 wherein the delivery media are dispersed within the erodible binder disposed above the surface of the scaffolding.

### Claim 132

A method of treating a patient vasculature, comprising:
deploying a stent at an implant site of a vasculature, the stent comprising a scaffolding formed from an erodible material, the scaffolding comprising a plurality of releasable delivery media comprising an active agent, and wherein a surface of the delivery media is adapted to bind to the target region of the vasculature; and
allowing the delivery media to release from the scaffolding and be transported to a target region of the vasculature.

### Claim 133

A method of treating a patient vasculature, comprising:
deploying a stent at an implant site of a vasculature, the stent comprising a scaffolding formed from erodible material, the scaffolding comprising a plurality of releasable delivery media comprising an active agent, and wherein a surface of the delivery media comprises a substance incorporated into the surface for selectively binding the surface to a portion of the vasculature, the substance selected from the group consisting of a peptide, an antibody, a small-molecular ligand, and a specific receptor having an affinity to receptors found on endothelial cells; and
allowing the delivery media to release from the scaffolding and be transported to a target region of the vasculature.

### Claim 134

A method of treating a patient vasculature, comprising:
deploying a stent at an implant site of a vasculature, the stent comprising a scaffolding formed from erodible material, the scaffolding comprising a plurality of releasable delivery media comprising an active agent, and wherein the delivery media are incorporated on or within the scaffolding with an erodible binder, the binder holding the particles together on or within the scaffolding; and
allowing the delivery media to release from the scaffolding and be transported to a target region of the vasculature.

### Claim 135

A stent comprising:
a scaffolding formed from an erodible material; and
a delivery coating disposed over at least a portion of the scaffolding, the delivery coating comprising a releasable delivery media dispersed within an erodible binder material, wherein the binder material is adapted to erode and release the delivery media upon implantation of the stent.

### Claim 136 (depends on 135)

The stent of claim 135 wherein the delivery coating is selectively disposed over an abluminal surface or a luminal surface of the scaffolding.

### Claim 137 (depends on 135)

The stent of claim 135 wherein the erodible material is an erodible polymer.

### Claim 138 (depends on 135)

The stent of claim 135 wherein the erodible material is a corrodible metal.

### Claim 139 (depends on 135)

The stent of claim 135 wherein the binder material is selected from the group consisting of a bioabsorbable polymer and a biosoluble polymer.

### Claim 140 (depends on 135)

The stent of claim 135 wherein the delivery media comprises an active agent, the delivery media allowing for sustained-release of the active agent into a body of a patient upon release of the delivery media from the binder material.

### Claim 141 (depends on 135)

The stent of claim 135 further comprising an erodible top coating above the delivery coating, the top coating adapted to delay the release of the delivery media from the delivery coating.

### Claim 142

A stent comprising:
a scaffolding formed from an erodible material;
a delivery coating disposed over at least a portion of the scaffolding, the delivery coating comprising a releasable delivery media dispersed within an erodible binder material, wherein the binder material is adapted to erode and release the delivery media upon implantation of the stent, and wherein the delivery coating is selectively disposed over an abluminal surface or a luminal surface of the scaffolding.

### Claim 143

A stent comprising:
a scaffolding formed from an erodible material;
a delivery coating disposed over at least a portion of the scaffolding, the delivery coating comprising a releasable delivery media dispersed within an erodible binder material, wherein the binder material is adapted to erode and release the delivery media upon implantation of the stent, and wherein the delivery media comprises an active agent, the delivery media allowing for sustained-release of the active agent into a body of a patient upon release of the delivery media from the binder material.

### Claim 144

A method of fabricating a coated stent comprising:
applying a coating material to a stent scaffolding, the coating material comprising an erodible polymer dissolved in a solvent and a plurality of delivery media dispersed in the solvent; and
removing all or substantially all of the solvent to form a delivery coating over the scaffolding, the delivery coating comprising the plurality of delivery media dispersed in the erodible polymer, wherein the erodible polymer is adapted to erode and release the delivery media upon implantation of the stent.

### Claim 145 (depends on 144)

The method of claim 144 wherein the delivery coating is applied by spraying the coating material on the scaffolding or dipping the scaffolding in the coating material.

### Claim 146 (depends on 144)

The method of claim 144 wherein the coating material is selectively disposed over an abluminal surface or a luminal surface of the scaffolding to form an abluminal or luminal coating.

### Claim 147 (depends on 144)

The method of claim 144 wherein the stent scaffolding is formed from an erodible material.

### Claim 148 (depends on 147)

The method of claim 147 wherein the erodible material is an erodible polymer.

### Claim 149 (depends on 147)

The method of claim 147 wherein the erodible material is a corrodible metal.

### Claim 150 (depends on 144)

The method of claim 144 wherein the coating polymer is selected from the group consisting of a bioabsorbable polymer and a biosoluble polymer.

### Claim 151 (depends on 144)

The method of claim 144 wherein the delivery media comprises an active agent, the delivery media allowing for sustained-release of the active agent into a body of a patient upon release of the delivery media from the delivery coating.

### Claim 152 (depends on 144)

The method of claim 144 further comprising forming an erodible top coating above the delivery coating, the top coating adapted to delay the release of the delivery media from the delivery coating.

### Claim 153

A method of fabricating a coated stent comprising:
applying a coating material to a stent scaffolding, the coating material comprising an erodible polymer dissolved in a solvent and a plurality of delivery media dispersed in the solvent;
removing all or substantially all of the solvent to form a delivery coating over the scaffolding, the delivery coating comprising the plurality of delivery media dispersed in the erodible polymer, wherein the erodible polymer is adapted to erode and release the delivery media upon implantation of the stent; and
forming an erodible top coating above the delivery coating, the top coating adapted to delay the release of the delivery media from the delivery coating.
